Increased Plasma Lipocalin-2 Levels Correlate With Disease Severity and May Be a Marker of Acute Inflammatory Response in Patients With Psoriasis. Dermatol Reports 2022, 14 (4). https://doi.org/10.4081/dr.2022.9469.